Environmental chemical exposures—the exposome—now explain mortality variation better than genetics, yet remain largely unmeasured in population health studies. Systematic quantification of synthetic chemicals in biobank samples could identify disease drivers and inform large-scale risk reduction.
Key Points
- Exposome factors outperform genetic data for predicting mortality differences
- Chemical production increased 50-fold since 1950s; PFAS and plasticizers contaminate most people
- High PFAS exposure reduces sperm count by 50%; PCB exposure triples childhood IQ deficits
Longevity Analysis
The stalling of life expectancy gains in developed nations despite medical advances and lifestyle improvements points to a systematic blind spot: unmeasured chemical exposures accumulating across decades. Existing biobank samples hold the data needed to decode which specific synthetic chemicals drive age-related disease and early mortality, but this resource remains underutilized. Identifying and quantifying these exposures in biological samples would shift the focus from treatment of downstream chronic illness to elimination of upstream chemical drivers—a fundamentally different approach to healthspan optimization that mirrors historical wins like the phaseout of leaded fuel.
Original published by Longevity.Technology, by Guest Contributor.